(Q43273547)

19769599

18 November 2017

title

RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). (English)

1 reference

18 November 2017

1 reference

4

Steven D Targum

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493891&resulttype=core&format=json

14 May 2020

author name string

Gregory M Chandler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493891&resulttype=core&format=json

14 May 2020

Dan V Iosifescu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493891&resulttype=core&format=json

14 May 2020

Mark H Pollack

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493891&resulttype=core&format=json

14 May 2020

Maurizio Fava

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493891&resulttype=core&format=json

14 May 2020

publication date

1 October 2010

1 reference

19769599

CNS Neuroscience & Therapeutics

18 November 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493891&resulttype=core&format=json

14 May 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493891&resulttype=core&format=json

14 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493891&resulttype=core&format=json

14 May 2020

page(s)

322-325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493891&resulttype=core&format=json

Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association

14 May 2020

cites work

1 reference

12 December 2020

Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.

1 reference

12 December 2020

The definition and meaning of treatment-resistant depression

1 reference

12 December 2020

Nonfinancial conflicts of interest in research

1 reference

12 December 2020

Diagnosis and definition of treatment-resistant depression

1 reference

12 December 2020

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

12 December 2020

Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine

1 reference

12 December 2020

STAR*D: what have we learned?

1 reference

12 December 2020

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

1 reference

12 December 2020

The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study.

1 reference

12 December 2020

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Definition and epidemiology of treatment-resistant depression

1 reference

12 December 2020

10.1111/J.1755-5949.2009.00102.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493891&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493891&resulttype=core&format=json

14 May 2020

19769599

1 reference